CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
CausalMutation
|
disease |
CLINVAR |
Genetic spectrum of hereditary neuropathies with onset in the first year of life.
|
21840889 |
2011 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
Biomarker
|
disease |
MGD |
Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.
|
25552649 |
2015 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
CausalMutation
|
disease |
CLINVAR |
Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.
|
25552649 |
2015 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
GeneticVariation
|
disease |
UNIPROT |
Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
|
15241803 |
2004 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth disease Type 2E/1F (CMT2E/1F) is a peripheral neuropathy caused by mutations in neurofilament protein L (NFL), which is one of five neurofilament subunit proteins that co-assemble to form neurofilaments in vivo.
|
31574566 |
2019 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
Biomarker
|
disease |
CTD_human |
|
|
|
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
GeneticVariation
|
disease |
BEFREE |
Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E.
|
24887401 |
2014 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.
|
10841809 |
2000 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
CausalMutation
|
disease |
CLINVAR |
Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.
|
25448007 |
2015 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
GeneticVariation
|
disease |
UNIPROT |
Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E.
|
11220745 |
2001 |
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.
|
10841809 |
2000 |
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterogeneity in the properties of NEFL mutants causing Charcot-Marie-Tooth disease results in differential effects on neurofilament assembly and susceptibility to intervention by the chaperone-inducer, celastrol.
|
23618875 |
2013 |
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.
|
12566280 |
2003 |
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
|
15241803 |
2004 |
Charcot-Marie-Tooth disease, demyelinating, Type 1F
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
|
14733962 |
2004 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.
|
17052987 |
2007 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.
|
25877835 |
2015 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.
|
10841809 |
2000 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.
|
26645395 |
2016 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterogeneity in the properties of NEFL mutants causing Charcot-Marie-Tooth disease results in differential effects on neurofilament assembly and susceptibility to intervention by the chaperone-inducer, celastrol.
|
23618875 |
2013 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
We found decreased striatal expression of transcripts encoding PSD-95 and SAP-102 in bipolar disorder and of SAP-102 in major depression and schizophrenia, while no significant changes in NF--L and PSD-93 mRNAs were observed.
|
16023328 |
2005 |